Patients with LS who carry MLH1 germline mutations face a cumulative risk of developing EC by age 70 of approximately 54%, which is higher than the risk for other LS-associated cancers, such as CRC (41%) and ovarian cancer (20%) [79]. The gene discussed is MLH1; the disease is cancer.